Alternative approaches to IP regulation
DavidLegge (Talk | contribs) |
|||
| Line 1: | Line 1: | ||
| + | ''[[Intellectual Property and Pharmaceuticals | Return to IP Resources page]]'' | ||
| + | |||
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [[http://www.nhmrc.gov.au/funding/policy/_files/ipman.pdf web reference]] | Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [[http://www.nhmrc.gov.au/funding/policy/_files/ipman.pdf web reference]] | ||
| Line 18: | Line 20: | ||
Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]] | Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]] | ||
| − | |||
| − | |||
Revision as of 09:13, 10 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]
Brewster et al (2005) [Innovation Strategy Today]
ICRISAT Policy on IPRs [IP management]
Possible role for patent pooling in managing SARS [Patent Pooling]
Patent pools [Patent Pools]
Anti-commons in biomedical research [Anticommons]
Stiglitz on the Medical Prize Fund [BMJ]
